In the News
Moving the needle on diversity in clinical trials: where do we go from here?
Rose Blackburne discusses the latest regulatory requirements around diversity in clinical trials, how the industry is responding and what actions will help enable further progress in clinical trial health equity.
PPD/TFS fostering global awareness in rare disorders
Galina Nesterova, Executive Medical Director, and Stephen Peroutka, Vice President, discuss the importance of Rare Disease Day and PPD’s commitment to this area.
The sweet science of diabetes technology
Mona Eskandarian, Director of Project Management, comments on current trends in continuous glucose monitoring technology and the use of eDiaries in diabetes treatment.
PharmaVoice’s crystal ball: What’s next in drug innovation and clinical trials
Les Enterline expects the sourcing of clinical development talent for client engagements to remain highly competitive.
Thermo Fisher’s research business, PPD, to explore effective treatments for ARDS in large trial
The PPD clinical research business has been selected to start a Phase II clinical trial to investigate.
How an FSP team implementing standards can help ensure on-time delivery of trials
The authors outline how a functional service provider team implementing data standards within a global library can help to ensure the on-time delivery of clinical trials, while maintaining data quality and integrity.
Training for operational excellence
Samantha Hadfield comments on ways to streamline and expedite onboarding for FSP engagements.
Digital and decentralized solutions: challenges faced during eDiary build
The authors document two early-stage challenges that exist in the design and implementation of eDiaries.
Decentralized clinical trials: being audit-ready and avoiding pitfalls
Sanra Orset reviews trends in audit findings specific to DCTs and provides guidance on how to develop a new project delivery framework that will support audit readiness.
